Filing Details

Accession Number:
0001144204-12-010720
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-02-24 09:25:17
Reporting Period:
2012-02-21
Filing Date:
2012-02-24
Accepted Time:
2012-02-24 09:25:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1077183 Neogenomics Inc NGNM.OB Services-Testing Laboratories (8734) 742897368
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1518888 T Michael Dent 12701 Commonwealth Drive
Suite 9
Fort Myers FL US 33913
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-02-21 22,537 $1.75 0 No 4 S Direct
Common Stock Disposition 2012-02-21 12,398 $1.75 1,653,772 No 4 S Indirect Held in trust by spouse
Common Stock Disposition 2012-02-22 35,120 $1.71 1,618,652 No 4 S Indirect Held in trust by spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Indirect Held in trust by spouse
No 4 S Indirect Held in trust by spouse
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 24,000 Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock option (Right to buy) $0.25 2004-08-14 2014-08-13 0 400,000 Direct
Common Stock Warrant (Right to buy) $1.50 2007-06-07 2012-06-06 0 100,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2014-08-13 0 400,000 Direct
2012-06-06 0 100,000 Direct
Footnotes
  1. On April 27,2011 the Board of Directors approved and granted a restricted stock award of 24,000 shares of NeoGenomics common stock. The terms of the award call for 2,000 shares to vest on the last day of the next 12 quarters starting on June 30, 2011 as long as Mr. Dent remains a Director of the Company.